Retatrutide dosage for weight loss typically starts at 2 mg once weekly and increases to a maintenance dose of 4 mg to 12 mg, depending on individual response and tolerability. In Canada, this triple-agonist peptide is gaining attention for its ability to reduce appetite, slow gastric emptying, and increase energy expenditure. The retatrutide weight loss protocol mirrors the titration schedules used in clinical trials, where participants lost up to 24% of body weight over 48 weeks. If you are researching retatrutide in Canada, understanding the exact dosing schedule and realistic results is essential before you begin.
What Is Retatrutide and How Does It Work?
Retatrutide is an investigational peptide that activates three receptors: GLP-1, GIP, and glucagon. This triple action makes it more potent than single or dual agonists like semaglutide or tirzepatide. The glucagon component increases energy expenditure, while GLP-1 and GIP suppress appetite and improve insulin sensitivity. In phase 2 trials, retatrutide produced dose-dependent weight loss with a favorable safety profile. For researchers in Canada, this mechanism explains why the retatrutide dosage for weight loss can be lower than expected for similar effects.
Retatrutide Dosage for Weight Loss: Step-by-Step Protocol
The standard retatrutide weight loss protocol follows a weekly subcutaneous injection schedule. Start with 2 mg once weekly for the first four weeks. This allows your body to adapt and minimizes gastrointestinal side effects. After four weeks, increase to 4 mg weekly. If additional weight loss is needed and tolerated, you can escalate to 8 mg weekly, and finally to 12 mg weekly. Most users see significant results at 4 mg to 8 mg, so higher doses are not always necessary. Do not skip the titration phase; rapid dose increases lead to nausea, vomiting, and fatigue.
Sample Retatrutide Titration Schedule
- Weeks 1-4: 2 mg once weekly
- Weeks 5-8: 4 mg once weekly
- Weeks 9-12: 6 mg or 8 mg once weekly (based on response)
- Weeks 13+: 8 mg to 12 mg once weekly (maintenance)
Always inject on the same day each week, preferably in the abdomen or thigh. Rotate injection sites to avoid lipodystrophy. If you miss a dose, take it as soon as possible within 3 days; otherwise skip and resume your normal schedule.
Retatrutide Results: What to Expect in Canada
Clinical data shows that retatrutide produces rapid and sustained weight loss. In a phase 2 trial, participants on 12 mg weekly lost an average of 24.2% of body weight after 48 weeks. Even the 4 mg group lost 13.9% on average. Most weight loss occurs in the first 6 months, with continued but slower loss thereafter. Users in Canada report noticeable appetite suppression within the first week, often at the 2 mg starting dose. By week 8, many have lost 5% to 8% of their starting weight. Full results require 6 to 12 months of consistent use.
Retatrutide vs Semaglutide and Tirzepatide
Retatrutide outperforms both semaglutide and tirzepatide in head-to-head trial comparisons. Semaglutide 2.4 mg weekly yields about 15% weight loss over 68 weeks. Tirzepatide 15 mg weekly yields about 20% over 72 weeks. Retatrutide 12 mg weekly yields 24% over 48 weeks. The triple agonist effect is the key differentiator. For researchers in Canada, this means retatrutide may be the most effective peptide for weight loss currently available, though it is not yet approved by Health Canada.
Side Effects and Safety Considerations
The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, and constipation. These are dose-dependent and usually subside after 2 to 4 weeks. Starting at 2 mg and titrating slowly reduces these effects. Retatrutide also increases heart rate by 5 to 10 beats per minute, which is generally well tolerated but should be monitored. Rare but serious risks include pancreatitis, gallbladder disease, and medullary thyroid cancer (seen in rodent studies). Do not use retatrutide if you have a personal or family history of MEN2 or medullary thyroid cancer. In Canada, always source retatrutide from a reputable vendor that provides third-party testing.
How to Reconstitute and Store Retatrutide
Retatrutide typically comes as a lyophilized powder in 5 mg or 10 mg vials. Reconstitute with bacteriostatic water. For a 5 mg vial, add 1 mL of bacteriostatic water to get a concentration of 5 mg/mL. Then a 2 mg dose is 0.4 mL (40 units on an insulin syringe). For a 10 mg vial, add 2 mL to get 5 mg/mL, or 1 mL to get 10 mg/mL. Always use a new sterile syringe and alcohol swab. Store reconstituted retatrutide in the refrigerator at 2-8°C and use within 30 days. Unreconstituted powder can be stored frozen for up to 2 years.
Where to Buy Retatrutide in Canada
Retatrutide is not available at Canadian pharmacies because it lacks Health Canada approval. Researchers must buy retatrutide from online peptide vendors that ship to Canada. Prices vary widely: a 5 mg vial typically costs $80 to $150 CAD, while 10 mg vials range from $150 to $250 CAD. Always verify the vendor's third-party COA (Certificate of Analysis) for purity and peptide content. Avoid vendors that do not provide batch-specific testing. For more on sourcing research peptides in Canada, see our guide on where to buy BPC-157 5mg in Toronto for vendor vetting tips that apply to all peptides.
Retatrutide Dosage for Weight Loss: Common Questions
Can I use retatrutide every day instead of weekly?
No. Retatrutide has a half-life of about 6 days, so once-weekly dosing is optimal. Daily dosing would increase side effects without added benefit.
What if I don't lose weight on 4 mg?
Increase to 8 mg after 4 weeks at 4 mg. If still no response after 4 more weeks, consider 12 mg. Some non-responders may need the highest dose.
Is retatrutide legal in Canada?
Retatrutide is not approved for human use in Canada. It is sold for research purposes only. Possession for personal use is generally not prosecuted, but importing large quantities may attract attention.
How long should I stay on retatrutide?
Most protocols last 6 to 12 months. After reaching goal weight, you can taper down to a maintenance dose of 2 mg to 4 mg weekly or stop entirely. Weight regain is common after stopping, so a long-term plan is essential.
Comparing Retatrutide to Other Weight Loss Peptides
Retatrutide is not the only peptide used for weight loss. AOD-9604 and HGH Fragment 176-191 are popular alternatives, but they work through different mechanisms and produce less dramatic results. For a detailed comparison of AOD-9604 dosing and outcomes, read our article on AOD-9604 dosage for weight loss. If you are also interested in muscle recovery peptides, our guide on peptides for muscle recovery covers BPC-157 and TB-500 protocols. For French-speaking researchers, we have a dedicated page on BPC-157 dosage for muscle recovery.
Final Word on Retatrutide Dosage and Protocol
Retatrutide dosage for weight loss is straightforward: start low, titrate slowly, and monitor your response. The 2 mg to 4 mg to 8 mg weekly schedule is safe and effective for most users. Results in Canada mirror global data: expect 10% to 20% weight loss over 6 to 12 months. Always source from a trusted vendor, reconstitute correctly, and watch for gastrointestinal side effects. With the right protocol, retatrutide is a powerful tool for significant and lasting weight loss.